These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2522993

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Interaction of permanently uncharged dopamine analogs with the D-2 dopaminergic receptor.
    Wallace RA, Farooqui T, Wallace L, Ares J, Chang YA, Miller D, Uretsky N.
    Biochem Pharmacol; 1988 May 15; 37(10):2077-84. PubMed ID: 2967702
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Charged analogues of chlorpromazine as dopamine antagonists.
    Harrold MW, Chang YA, Wallace RA, Farooqui T, Wallace LJ, Uretsky N, Miller DD.
    J Med Chem; 1987 Sep 15; 30(9):1631-5. PubMed ID: 2887659
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of buflomedil (4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxy phenyl)-1-butanone hydrochloride) on the function of striatal dopaminergic neurons.
    Koda H, Hashimoto T, Kuriyama K.
    Jpn J Pharmacol; 1989 Feb 15; 49(2):215-23. PubMed ID: 2659861
    [Abstract] [Full Text] [Related]

  • 9. The interaction of ammonium, sulfonium, and sulfide analogues of metoclopramide with the dopamine D2 receptor.
    Harrold MW, Sriburi A, Matsumoto K, Miller DD, Farooqui T, Uretsky N.
    J Med Chem; 1993 Oct 15; 36(21):3166-70. PubMed ID: 8230103
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhancing effect of dopamine blockers on evoked acetylcholine release in rat striatal slices: a classical D-2 antagonist response?
    Boireau A, Chambry J, Dubedat P, Farges G, Carruette AM, Zundel JL, Blanchard JC.
    Eur J Pharmacol; 1986 Aug 22; 128(1-2):93-8. PubMed ID: 2875894
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P, Olianas MC, Gessa GL.
    Mol Pharmacol; 1985 Aug 22; 28(2):138-45. PubMed ID: 2410769
    [Abstract] [Full Text] [Related]

  • 16. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S, Markstein R.
    J Neurochem; 1986 Apr 22; 46(4):1058-67. PubMed ID: 2936868
    [Abstract] [Full Text] [Related]

  • 17. Dopamine agonists: effects of charged and uncharged analogues of dopamine.
    Chang YA, Ares J, Anderson K, Sabol B, Wallace RA, Farooqui T, Uretsky N, Miller DD.
    J Med Chem; 1987 Jan 22; 30(1):214-8. PubMed ID: 3806598
    [Abstract] [Full Text] [Related]

  • 18. Correspondency between different affinity states and target size of the bovine striatal D2 dopamine receptor.
    Kuno T, Tanaka C.
    Biochem Biophys Res Commun; 1983 Nov 30; 117(1):65-70. PubMed ID: 6197972
    [Abstract] [Full Text] [Related]

  • 19. Modulation of the endogenous acetylcholine release from rat striatal slices.
    Alberch J, Marsal J, Solsona C.
    Brain Res; 1985 Nov 04; 346(2):353-6. PubMed ID: 2996707
    [Abstract] [Full Text] [Related]

  • 20. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S, Nahorski SR.
    Eur J Pharmacol; 1982 Jul 09; 81(2):273-85. PubMed ID: 7117377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.